The 'Outperform' rating from a reputable analyst like David Nierengarten suggests that he expects the stock to do better than the market average. This could potentially attract more investors to the stock, driving up its price in the short term. The maintained price target of $33 also indicates that the analyst believes the stock is currently undervalued, which could further boost investor interest.